Introduction {#Sec1}
============

In 1945, Alexander Fleming, the discoverer of Penicillin, warned of antibiotic resistance. Today, the WHO echoes this warning, calling antibiotic resistance a global threat to human health. Humans are at the center of the modern rise of resistance. The human gut^[@CR1]^, clinical samples^[@CR2],[@CR3]^, soil^[@CR4],[@CR5]^, and wastewater^[@CR6]^ all harbor resistant bacteria and resistance genes. At the heart of modern resistance development is a human-centered network of clinics, industry, private homes, farming, and wastewater. Recent studies suggest that wastewater contains a significant amount of antibiotic resistant *E*. *coli*, specifically extended-spectrum beta-lactamase-producing *E*. *coli*^[@CR7]^. Particularly, multidrug-resistant (MDR) clones (normally defined as those resistant to three or more drug classes^[@CR8]^) are of great concern. Past studies have documented the presence of MDR *E*. *coli* isolates in wastewater on the basis of phenotypic resistance testing^[@CR9]^, but a comprehensive analysis of the clonal composition of MDR *E*. *coli* in wastewater employing whole genome analysis is largely lacking. Therefore, the current information on the genomic diversity of antibiotic resistant *E*. *coli* in wastewater is very limited. Recent metagenomic studies have documented that human-associated bacteria are strongly reduced in the wastewater and its treatment process^[@CR10]^. To investigate the genomic diversity as well as virulence genes and resistance determinants for wastewater *E*. *coli*, we proceeded as sketched in Fig. [1](#Fig1){ref-type="fig"}. We collected 1178 *E*. *coli* isolates from a waste treatment plant's inflow and outflow in the city of Dresden, Germany. We selected 20 antibiotics, which are the most prescribed ones in the area from which the wastewater inflow originates (data provided by the public health insurer AOK). We analyzed the isolates' resistance to these 20 antibiotics and selected 103 isolates for whole genome sequencing. Our analysis reveals a surprisingly high genomic diversity of MDR *E*. *coli* in the wastewater with very flexible genomes harboring a high variation of virulence genes and resistance determinants. Using this diversity, we developed a computational approach to identify not only known, but also novel genes correlating with resistance.Figure 1Wastewater plays an important role in antibiotic resistance development. Wastewater *Escherichia coli* isolates were tested for antibiotic resistance and sequenced. Many isolates are multi-drug resistant and have markers often found in pathogenic isolates. Their large pan-genome is a source of potentially novel resistance genes.

Results {#Sec2}
=======

The wastewater pan-genome {#Sec3}
-------------------------

The concept of evolution implies that genomes of organisms of the same species differ. Differences range from single nucleotide polymorphisms to large genome rearrangements. As a consequence, *E*. *coli* possesses a core of genes present in all genomes, as well as genes only present in some genomes, or even just in one. The union of all of these genes is called the pan-genome. It is believed, that the *E*. *coli* core genome comprises around 1400--1500 genes, while the pan-genome may be of infinite size^[@CR11]^.

To assess the degree of genomic flexibility of the wastewater isolates, we relate the wastewater pan-genome and the wastewater core genome. At 16582 genes, the wastewater pan-genome is nearly six times larger than the wastewater core genome of 2783 genes, a reservoir of some 14000 genes. Despite this large reservoir, the size difference of nearly 1000 genes between the wastewater *E*. *coli* core genome and the whole species core genome suggests that the full diversity of *E*. *coli* is still not covered in our wastewater sample.

The balance between maintaining the core genome and spending energy on acquisition of new genetic material can be captured by the ratio of the core genome size and the average genome size, which is 4700 genes in our sample. This means that only 1400/4700 = 30% of genes in our wastewater *E*. *coli* are core genes. Most of the non-core genes are very unique and appear only in one or two isolates each. More precisely, 50% of the pan-genome genes appear in only one or two isolates each. This implies that the investigated wastewater *E*. *coli* are highly individual.

This high diversity is also illustrated in Fig. [2](#Fig2){ref-type="fig"}, which compares the wastewater *E*. *coli* to a clinical dataset of *E*. *coli*. The figure clearly shows that the *E*. *coli* of clinical origin are more homogeneous and hence their pan-genome is smaller. In contrast, the diversity of the wastewater *E*. *coli* match other datasets comprising mixtures of commensal and pathogenic *E*. *coli*, as well as *Shigella* genomes (see Table [1](#Tab1){ref-type="table"}). This underlines the great diversity of *E*. *coli* genomes in the wastewater. Interestingly, the variation of the wastewater genomes after the treatment plant was not reduced.Figure 2The pan-genome at the outflow has the same size as at the inflow, suggesting that highly flexible *Escherichia coli* emerge from a treatment plant. The wastewater pan-genome is larger than a clinical pan-genome and of similar size to (see Table [1](#Tab1){ref-type="table"}) highly diverse samples comprising pathogenic, commensal, and lab *Escherichia coli*, as well as *Shigella*.Table 1Highly diverse samples comprising pathogenic, commensal, and lab *Escherichia coli*, as well as *Shigella*.RefPanCoreStrainsPath.Comm.Lab*Shig*.This study16582278392286200Kaas *et al*.^[@CR54]^16373170218617115Vieira *et al*.^[@CR55]^1498619572921806Gordienko *et al*.^[@CR56]^1200020003216637Lukjancenko *et al*.^[@CR57]^13000147253351170Rasko *et al*.^[@CR58]^1300023441714120Touchon *et al*.^[@CR28]^1143219762010307Path. = Pathological.Comm. = Commensal.Lab. = Laboratory.Shig. = *Shigella*.

Resistance genes in the wastewater pan-genome {#Sec4}
---------------------------------------------

Wastewater *E*. *coli* are known to host antibiotic resistance genes. While there are many known resistance genes (see e.g. CARD^[@CR12]^), they fall mostly into a few groups, such as beta-lactamases. Here, we seek to confirm and expand the space for resistance genes. Firstly, we measured antibiotic resistance in all 1178 isolates to the 20 antibiotics. As mentioned above, these 20 antibiotics include the most widely used antibiotics in the wastewater plant's region. They included kanamycin and cephalotin, which are under debate regarding their intrinsic resistance, but to which *E*. *coli* are shown to be susceptible in many studies^[@CR13]--[@CR18]^. Figure [3](#Fig3){ref-type="fig"} shows that 4 isolates are susceptible to kanamycin and 45 to cephalotin.Figure 31178 Wastewater *Escherichia coli* isolates were tested for antibiotic resistance to 20 antibiotics covering 4 main classes as well as the Miscellenous class (chloramphenicol and fosfomycin). Nearly all isolates are multi-drug resistant. Isolates were highly susceptible to carbapenems (meropenem and imipenem) which are beta-lactams. Isolates were also more susceptible to fluoroquinolones than to tetracyclins and aminoglycosides. The outflow isolates (n = 322) show similar resistance as inflow (n = 856) (p-value 0.0001), suggesting that wastewater treatment is not reducing resistance development.

Figure [3](#Fig3){ref-type="fig"} reveals a high degree of resistance and big differences between different antibiotics, including a general trend indicating greater resistance to antibiotics that have been available for longer. Specifically, isolates were significantly more resistant to antibiotics from the 50 s and 60 s namely, chloramphenicol, cephalotin, doxycycline, fosfomycin, gentamicin, kanamycin, nalidixic acid, tetracycline & tobramycin, than the more recent antibiotics (Welch test, p-value \< 0.0025, also significant without including kanamycin and cephalotin). However, there is no significant difference in the number of resistances between isolates from the inflow and the outflow (p-value 0.0001), suggesting that wastewater treatment is not affecting resistance.

Next, we tried to predict the resistance observed in Fig. [3](#Fig3){ref-type="fig"} using known resistance genes. To this end, we employed ResFinder^[@CR19]^ and could predict resistances across all classes of drugs (see Supp Fig. [4](#MOESM1){ref-type="media"}) at an accuracy of 46%. While these are promising results, they show also that the known resistance genes used in the analysis are not sufficient for a perfect prediction. Therefore, we wanted to expand the link from genotype to phenotype by going beyond known resistance genes. Thus, we correlated the presence of each gene in the sequenced isolates with their phenotypic antibiotic resistance profiles.

Meropenem and imipenem are clinically important antibiotics, which are very effective, as can be seen in Fig. [3](#Fig3){ref-type="fig"}. Hardly any of the isolates are resistant to them. Since both drugs work so well, correlation of presence and absence of genes to resistance/susceptibility will be naturally poor. Hence, we have excluded both compounds from the correlation analysis. For each of the 18 remaining antibiotics, we list the top ten correlating genes in the table shown in Fig. [4](#Fig4){ref-type="fig"}. These 180 genes comprise 88 unique confirmed genes, including many well-known resistance genes, such as efflux pumps (MT1297 and *emr*E), membrane and transport proteins (*aida-*I, *yia*V, *yij*K, *pit*A, *ics*A, and *pag*N), tetracycline (*tet*A, *tet*R, and *tet*C), chloramphenicol (*cat*), and piperacillin (the beta lactamase *bla*2) resistance genes. Based on available literature, genes that are known to mediate resistance against the respective antibiotic (e.g. *tetA* mediates resistance against tetracycline and *cat* mediates resistance against chloramphenicol) were highlighted in yellow. However, the 180 genes also comprise a large number of open reading frames encoding hypothetical proteins (41) and genes not yet linked to antibiotic resistance (116). These genes have to be studied further to determine whether they are novel resistance genes or just correlating. (e.g. because they are on the same genetic element with a resistance gene). As a consequence, the *tet* gene, which is a known resistance gene against tetracyclins is highlighted in the table shown in Fig. [4](#Fig4){ref-type="fig"}, but occurrences of *tet*, which appear among the quinolones are not highlighted in yellow. Nearly all of the identified genes are found both in inflow and outflow genomes suggesting that the wastewater treatment does not impact on the presence or absence of known resistance genes and genes correlating with resistance.Figure 4Top 10 correlating genes for 18 antibiotics from correlation of genomes to resistance phenotype. Antibiotics were color-coded based on antibiotic class following the scheme in Fig. [3](#Fig3){ref-type="fig"}. The highlighted yellow boxes represent genes involved in resistance to the respective antibiotics based on available literature.

Virulence genes {#Sec5}
---------------

Generally, *E*. *coli* strains exhibit great variation. Many exist as harmless commensals in the human gut, but some are classified as intra- (InPEC) or extra-intestinal pathogenic *E*. *coli* (ExPEC^[@CR20]^). Based on their virulence genes profile the pathogenic potential of *E*. *coli* isolates can be determined^[@CR7]^. The sequenced isolates contain some 700 of nearly 850 *E*. *coli* protein sequences representing 400 virulence factors and their isoforms in the virulence factor database^[@CR21]^, averaging to 153 and to 155 virulence factors per isolate for inflow and outflow, respectively. Hence, there is no significant difference (Welch test, CI 95%) between inflow and outflow. In particular, we found combinations of virulence factors for 16 isolates (see methods), which are indicative of ExPEC. Eight of these 16 isolates were obtained from the outflow of the treatment plant (see Fig. [5](#Fig5){ref-type="fig"}).Figure 5Phylogeny of wastewater *Escherichia coli* from the inflow (n = 50) and the outflow (n = 42) of a wastewater treatment plant. Phylogenetic tree, multi-locus sequence types (shown as numbers in black), and phylogroups of 92 sequenced wastewater *Escherichia coli* isolates reveal 16 potential ExPEC isolates (marked with a black star) in phylogroups B2 (yellow) and D (green), which are associated with pathogenicity. Half of these 16 isolates stem from the outflow of the treatment plant.

Besides the presence of known virulence factors, pathogenic isolates are more likely to be member of certain multi-locus sequence types^[@CR22]^ and phylogroups^[@CR23],[@CR24]^. Broadly, *E*. *coli* has seven phylogroups, A, B1, B2, D D, E, F^[@CR25]^. Commensal as well as intestinal pathogenic *E*. *coli* fall mostly into groups A and B1^[@CR26]^ and ExPEC into B2 and D^[@CR23]^. Figure [5](#Fig5){ref-type="fig"} shows a phylogenetic tree of the sequenced wastewater *E*. *coli* isolates along with the commensal phylogroups A (red) and B1 (blue) and the pathogenicity-associated groups B2 (yellow) and D (green), as well as the finer-grained multi-locus sequence types. The tree is based on genomic variations compared to the reference genome of *E*. *coli* K12 MG1655. Figure [5](#Fig5){ref-type="fig"} reveals that nearly one third of isolates belong to group B2 and D, in which ExPEC are usually found. In particular, B2 and D include 14 of the 16 potential ExPEC isolates. Remarkably, half of the B2 and D isolates are from the wastewater treatment plant's outflow. To provide a scale for phylogenetic relationships of isolates in the tree, consider isolates 1, 2 and 3; isolate 1 is very close to isolate 2, but very far from 3. Isolates 1 and 2 have 25,218 single nucleotide polymorphisms (SNPs) in common, while 1 and 3 share only 4,928 SNPs. Overall, the number of shared SNPs ranges from 647 to 25218 averaging at 5271 SNPs (at a standard deviation of 3514).

Discussion {#Sec6}
==========

Pan and core genome {#Sec7}
-------------------

It is well known that wastewater treatment reduces the bacterial abundance, in addition a recent metagenomic study has shown that the bacterial community in wastewater is very different to the human gut community and that the number of detected genera is reduced in the wastewater^[@CR10]^. Consequently, our expectation was that the genomic diversity of *E*. *coli* should be reduced. We were very surprised to find an unexpectedly high genomic diversity, which is illustrated in the large pangenome. A possible explanation for this high genomic diversity is that the *E*. *coli* cells within the wastewater originate not only from human faeces, but also from a multitude of different animal faeces collected via the surface runoff into the sewers. This would also explain why the pangenome of the wastewater *E*. *coli* is considerably larger than the clinical pangenome reported by Land *et al*.^[@CR27]^. Generally, many authors have pointed out that *E*. *coli* has a large and flexible pan genome. Lapierre *et al*. argue that *E*. *coli* appears to have unlimited ability to absorb genetic material and hence its pan genome is open^[@CR11]^. In a recent study comprising over 2000 genomes Land *et al*. put this into numbers and arrive at a pan genome of 60000--89000 gene families for over 2000 sequenced *E*. *coli* genomes^[@CR27]^. The study by Land *et al*. (24) is based on clinical isolates, in contrast our study is the first, which has calculated the pangenome of *E*. *coli* for wastewater. Interestingly, our results seem to be in concordance and suggest that within our study we still have not reached the saturation of the detected diversity (Fig. [2](#Fig2){ref-type="fig"}), indicating that the full genomic diversity of *E*. *coli* in the wastewater is probably even larger than what we report here. Worryingly, this is also reflected in a high diversity of resistance and virulence genes. This documents that the wastewater contains a significant amount of multi-drug resistant (MDR) *E*. *coli*, which also carry a suit of virulence genes suggesting that some of those MDR have a pathogenic potential. Furthermore, we did not find a significant difference in genomic diversity between inflow and outflow of the wastewater treatment plant, suggesting that selection against genome diversity and resistance determinants does not seem to occur.

Pathogenic potential and resistance {#Sec8}
-----------------------------------

Resistant bacteria may or may not be pathogenic. While ultimate proof for pathogenicity can only be obtained from *in vivo* studies, we wanted to analyse the genomes for markers likely to be found in pathogenic bacteria. Here we chose to consider three independent approaches: classification by phylogenetic groups, by multi-locus sequence tags, and by identification of specific virulence factors (see methods). While the three approaches showed consistent results, they are by no means proof for pathogenicity, since there can be exceptions to these classification rules. As an example, consider the strain ED1a (O81), which was isolated from a healthy man, but belongs to the phylogenetic group B2^[@CR28]^. Similarly, pathogenicity may not only arise from the acquisition of genes, but also from the loss^[@CR29]^.

Regarding resistance there are similar confounding factors. Bacteria may be inherently resistant since generally antibiotic resistance is ancient^[@CR30]^ and naturally occurring in the environment. Nonetheless, there are pronounced differences between pristine and human environments^[@CR24]^. This is also supported by Fig. [3](#Fig3){ref-type="fig"}, which shows that antibiotics introduced in the 50 s and 60 s have more resistances than those introduced later (p-value \< 0.0025), which suggests, that the naturally occurring resistances do not play a major role in the emergence of observed resistances.

From clinic to river {#Sec9}
--------------------

We have shown that there are *E*. *coli* at the wastewater outflow, which are multi-drug resistant and have markers found in pathogenic bacteria. But are they abundant enough to have an impact in the aquatic system they are released into? They do. The percentage of possibly pathogenic *E*. *coli* in the outflow is considerable and may correspond to a large absolute amount. Caucci *et al*. quantified the amounts of eight antibiotic resistance genes at the inflow and outflow of a wastewater treatment plant^[@CR31]^. They found in the order of 10^4^ to 10^8^ copies at the inflow and a reduction of three orders of magnitude at the outflow. They argue that the reduction relates directly to the bacterial removal rate of the treatment plant and their numbers show that despite removal, substantial amounts of resistance genes remain. Also, the number of *E*. *coli* are assessed at the wastewater treatment plant regularly and they are between 10^4^ and 10^5^ Colony Forming Units (CFU)/ml for the inflow and 10^2^ and 10^3^ (CFU/ml) for the outflow respectively and the numbers are comparable to other studies^[@CR32]^. Generally, if an average of 100 *E*. *coli* colony forming units (CFU) are released per ml, then 10^13^ CFUs per day are released (assuming a release of 10^5^ m^3^ per day). This is in accordance with Manaia *et al*., who showed that 10^10^--10^14^ CFU of ciprofloxacin-resistant bacteria are released by a mid-sized wastewater treatment plant^[@CR33]^. Supporting these results, a study in a Japanese river shows the presence of pathogenic *E*. *coli*^[@CR34]^. In this study they sequenced over 500 samples from the Yamato river and most of their prevalent multi-drug resistant and clinical strains are also present in our samples. In a related study, Czekalski *et al*. found that particle-associated wastewater bacteria are the responsible source for antibiotic resistance genes in the sediments of lake Geneva in Switzerland^[@CR35]^. Assuming that the river Elbe is comparable to these aquatic systems, it suggests, that the urban environment (including clinics) and river are connected with wastewater treatment plants in between.

Composition of phylogroups {#Sec10}
--------------------------

It is interesting to compare the breakdown into phylogenetic groups of wastewater *E*. *coli* to compare samples from human and animal environments. It is, e.g., known that the phylogenetic group B2 is more abundant among commensal *E*. *coli* from human faeces (43%) than from farm animals (11%)^[@CR36]^. Therefore, the composition of wastewater *E*. *coli* as shown in Fig. [5](#Fig5){ref-type="fig"} resembles commensal *E*. *coli* from farm animals more closely. Similarly, Tenaillon *et al*. find that groups A and B1 make up one third in human faeces^[@CR36]^, whereas we find two thirds. This suggests that animal feces play an important role for resistance also of urban wastewater treatment plants. Besides the diverse environments such as soils and activated sludge, animal feces are probably part of the explanation for the high observed genomic diversity.

Random sampling and novel resistance mechanisms {#Sec11}
-----------------------------------------------

The initial 1178 isolates were sampled randomly over different times of the year, from two different inflows and the outflow of the wastewater treatment plant. In contrast, the 103 sequenced isolates were chosen in such way that all of the phenotypes encountered were represented (see methods). Within a phenotype group isolates were chosen randomly. This random, but representative choice and the subsequent link from genotype to phenotype is an example of high-throughput hypothesis-free analysis. And although, there was no pre-defined resistance mechanism, which we aimed to hit, many of the well-known resistance genes were ranked high. This supports the hope that high-throughput, hypothesis-free methods such as deep sequencing will help to uncover novel resistance mechanisms and in particular that some of the top correlating genes will prove to have a causal link to resistance. The results show that the here outlined computational approach to correlate genomic and phenotypic information for wastewater *E*. *coli* significantly assists to identify a larger part of the existing resistome of *E*. *coli*. However, a limitation to the method is that it can pinpoint correlating genes if resistances have manifested themselves, but not when they are yet to emerge. For future investigations, it will be interesting to expand the analysis to mutations within genes (e.g. there are well-known mutations in gyrA and parC conferring quinolone resistance) and in non-coding regions (mutations in the promoter region of ampC conferring beta-lactam resistance).

Conclusion {#Sec12}
==========

Overall, we have shown for the first time that *E*. *coli* isolates from wastewater have a surprisingly large pan-genome, which harbors virulence genes, known resistance genes and genes correlating with resistance. We developed a computational approach based on genomic and phenotypic correlation for *E*. *coli* and show that applying this to wastewater will discover novel parts of the resistome in *E*. *coli*. Finally, together with the estimates on absolute *E*. *coli* abundance, we could demonstrate that there is a considerable pathogenic potential in the outflow of a wastewater treatment plant. Using *E*. *coli* as an example, this study demonstrates the importance of investigating wastewater with modern bioinformatics and strain specific genomic analysis in order to estimate the extent of genomic variation and resistance determinants for bacteria with clinical relevance present in the environment.

Methods {#Sec13}
=======

Collection {#Sec14}
----------

1178 samples were collected from the municipal wastewater treatment plant Dresden, Germany. Samples were collected on 11/4/2012 (Spring 2012), 30/7/2012 (Summer 2012), 21/1/2013 (Winter 2012), 27/3/2013 (Spring 2013), 6/8/2013 (Summer 2013), 14/10/2013 (Autumn 2013), and 17/12/2013 (Winter 2013). Samples were collected either at the outflow (n = 322, OUT) or at one of two inflow locations (n = 856, Altstadt ALT and Neutstadt NEU), representing the area south and north of the river Elbe.

Isolation {#Sec15}
---------

*E*. *coli* and total coliforms bacteria were enumerated via serial fold dilution plating of the original wastewater (triplicate samples). Wastewaters were diluted in double distilled water, until the enumeration of bacterial colonies was possible. *E*. *coli* and coliform counts were always performed in triplicates. The *E*. *coli* colonies were selected and picked after overnight growth at 37 °C on a selective chromogenic media (OXOID Brilliance *Escherichia coli*/Coliform Selective Agar, Basingstoke, England). All single colonies recognised as chromogenically positive E.coli were picked. To reduce the dilution effect on *E*. *coli* diversity, extra effort was placed for colony picking at the lowest fold dilution. To minimize the risk of colony contamination, picked colonies were spiked a second time on the same selective media and pure single colonies were grown overnight on LB media at 37 °C and stored on glycerol stock at −80 °C. For the cell counting we used mFC Agar and incubated the plates at 44 °C for 20 h ( ± 2 h).

Resistance phenotyping {#Sec16}
----------------------

Antibiotic resistance phenotypes were determined by the agar diffusion method using 20 antibiotic discs (OXOID, England) according to EUCAST (or CLSI when EUCAST was not available)^[@CR7],[@CR9]^. The selected drugs belong to the most commonly prescribed antibiotics for diseases caused by bacteria according to the German health insurance AOK Plus: piperacillin (100 *µg*), nalidixic acid (30 *µg*), chloramphenicol (30 *µg*), imipenem (10 *µg*), cefotaxime (30 *µg*), cephalotin (30 *µg*), kanamycin (30 *µg*), tetracycline (30 *µg*), gentamicin (10 *µg*), amikacin (30 *µg*), ciprofloxacin (5 *µg*), fosfomycin (50 *µg*), doxycycline (30 *µg*), cefepime (30 *µg*), ceftazidime (10 *µg*), levofloxacin (5 *µg*), meropenem (10 *µg*), norfloxacin (10 *µg*), cefuroxime sod. (30 *µg*), tobramycin (10 *µg*)^[@CR31]^. After 24 hours of incubation at 37 °C, the resistance diameters were measured. Clustering of antibiotics and of isolates was performed using the R function heatmap.2 from the R library^[@CR37]^ Heatplus and hierarchical clustering of matrices based on Euclidean distances between isolates and between antibiotics.

Sequencing {#Sec17}
----------

To select isolates representative of phenotype, we clustered isolates according to the diameters of inhibition zone against the 20 antibiotics using k-means clustering based on Euclidean distances between isolates (vectors of 20 inhibition zone diameters). The analysis and graphs were produced using R version 3.2.4^[@CR37]^. As clusters may be highly skewed in number of cluster members, we tested all cluster numbers from 1 to 100 and plotted within class sum of squares against *k*. At *k* = 47, the sum of squares tails off and there is a steep local decrease, so that *k* = 47 was fixed as k-means parameter. We obtained 103 isolates, which were subsequently used for sequencing and further analysis. To further validate the choice, we plotted the average number of resistances against number of isolates and antibiotics vs. number of isolates for the total 1178 and the selected 103 isolates (see Supp Fig. [1](#MOESM1){ref-type="media"}) and concluded that both distributions are roughly similar. 3000 ng DNA were extracted from each of the 103 selected isolates using MasterPure extraction kit (Epicentre) according to the manufacturer's instructions. Sequencing was performed on an Illumina MiSeq system using V3 chemistry and the Nextera XT kit for library preparation.

Assembly {#Sec18}
--------

Genomes were assembled with Abyss (version 1.5.2)^[@CR38]^. In order to optimize *k* for the best assembly, k-mer values had to be empirically selected from the range of 20--48 (see Supp Fig. [2](#MOESM1){ref-type="media"}) on a per sample basis to maximize contiguity^[@CR3]^. To determine the k-mer length that achieved highest contiguity, the 28 assemblies per draft genome/isolate were compared based on *N50* values. 11 assemblies with an *N50* statistic of less than 5 × 10^4^ bp were excluded^[@CR39]^.

Genes {#Sec19}
-----

Reference gene clusters were computed from 58 complete *E*. *coli* genomes (see Table [2](#Tab2){ref-type="table"}) available in June 2015 from NCBI. Genes were identified in wastewater and reference genomes using Prokka (version 1.11)^[@CR40]^. Genes were clustered at 80% using CD-HIT^[@CR41]^ (version 4.6.3, arguments -n 4 -c 0.8 -G 1 -aL 0.8 --aS 0.8 -B 1). Genes with over 90% sequence identity, but only 30% coverage, as well as genes with 80% or greater identity and covered to phage and virus sequences^[@CR42]^ were discarded. A gene cluster is defined to be present in an isolate if there is a Prokka gene in the genome, which is longer than 100 amino acids and has over 80% sequence identity and coverage against the gene cluster representative.Table 2Accession numbers of 92 de novo assembled wastewater *Escherichia coli* genomes.BioprojectBiosampleAccessionstrainPRJNA380388SAMN06641941NBBP00000000Escherichia coli Win2013_WWKa_OUT_3PRJNA380388SAMN06641940NBBQ00000000Escherichia coli Win2013_WWKa_OUT_29PRJNA380388SAMN06641933NBBR00000000Escherichia coli Win2013_WWKa_OUT_18PRJNA380388SAMN06641932NBBS00000000Escherichia coli Win2013_WWKa_OUT_24PRJNA380388SAMN06641931NBBT00000000Escherichia coli Win2013_WWKa_OUT_1PRJNA380388SAMN06641928NBBU00000000Escherichia coli Win2013_WWKa_NEU_65PRJNA380388SAMN06641927NBBV00000000Escherichia coli Win2013_WWKa_NEU_20PRJNA380388SAMN06641926NBBW00000000Escherichia coli Win2013_WWKa_NEU_60PRJNA380388SAMN06641901NBBX00000000Escherichia coli Win2013_WWKa_ALT_23PRJNA380388SAMN06641884NBBY00000000Escherichia coli Win2012_WWKa_OUT_49PRJNA380388SAMN06641883NBBZ00000000Escherichia coli Win2012_WWKa_OUT_8PRJNA380388SAMN06641882NBCA00000000Escherichia coli Win2012_WWKa_OUT_34PRJNA380388SAMN06641881NBCB00000000Escherichia coli Win2012_WWKa_OUT_35PRJNA380388SAMN06641880NBCC00000000Escherichia coli Win2012_WWKa_OUT_29PRJNA380388SAMN06641879NBCD00000000Escherichia coli Win2012_WWKa_OUT_26PRJNA380388SAMN06641878NBCE00000000Escherichia coli Win2012_WWKa_OUT_33PRJNA380388SAMN06641877NBCF00000000Escherichia coli Win2012_WWKa_OUT_21PRJNA380388SAMN06641876NBCG00000000Escherichia coli Win2012_WWKa_OUT_2PRJNA380388SAMN06641875NBCH00000000Escherichia coli Win2012_WWKa_NEU_7PRJNA380388SAMN06641874NBCI00000000Escherichia coli Win2012_WWKa_OUT_14PRJNA380388SAMN06641873NBCJ00000000Escherichia coli Win2012_WWKa_NEU_51PRJNA380388SAMN06641872NBCK00000000Escherichia coli Win2012_WWKa_NEU_31PRJNA380388SAMN06641871NBCQ00000000Escherichia coli Win2012_WWKa_NEU_37PRJNA380388SAMN06641870NBCR00000000Escherichia coli Win2012_WWKa_NEU_16PRJNA380388SAMN06641869NBCS00000000Escherichia coli Win2012_WWKa_NEU_19PRJNA380388SAMN06641868NBCT00000000Escherichia coli Win2012_WWKa_NEU_12PRJNA380388SAMN06641867NBCU00000000Escherichia coli Win2012_WWKa_ALT_65PRJNA380388SAMN06641866NBCV00000000Escherichia coli Win2012_WWKa_NEU_1PRJNA380388SAMN06641865NBCW00000000Escherichia coli Win2012_WWKa_ALT_49PRJNA380388SAMN06641864NBCX00000000Escherichia coli Win2012_WWKa_ALT_54PRJNA380388SAMN06641863NBCY00000000Escherichia coli Sum2013_WWKa_OUT_5PRJNA380388SAMN06641862NBCZ00000000Escherichia coli Sum2013_WWKa_OUT_39PRJNA380388SAMN06641861NBDA00000000Escherichia coli Sum2013_WWKa_OUT_49PRJNA380388SAMN06641860NBDB00000000Escherichia coli Sum2013_WWKa_OUT_3PRJNA380388SAMN06641859NBDC00000000Escherichia coli Sum2013_WWKa_OUT_31PRJNA380388SAMN06641858NBDD00000000Escherichia coli Sum2013_WWKa_OUT_2PRJNA380388SAMN06641857NBDE00000000Escherichia coli Sum2013_WWKa_OUT_21PRJNA380388SAMN06641856NBDF00000000Escherichia coli Sum2013_WWKa_NEU_53PRJNA380388SAMN06641855NBDG00000000Escherichia coli Sum2013_WWKa_NEU_46PRJNA380388SAMN06641854NBDH00000000Escherichia coli Sum2013_WWKa_NEU_39PRJNA380388SAMN06641853NBDI00000000Escherichia coli Sum2013_WWKa_ALT_44PRJNA380388SAMN06641852NBDJ00000000Escherichia coli Sum2013_WWKa_NEU_29PRJNA380388SAMN06641851NBDK00000000Escherichia coli Spr2013_WWKa_OUT_27PRJNA380388SAMN06641844NBDL00000000Escherichia coli Sum2013_WWKa_ALT_41PRJNA380388SAMN06641843NBDM00000000Escherichia coli Sum2013_WWKa_ALT_27PRJNA380388SAMN06641842NBDN00000000Escherichia coli Spr2013_WWKa_OUT_56PRJNA380388SAMN06641841NBDO00000000Escherichia coli Sum2013_WWKa_ALT_20PRJNA380388SAMN06641840NBJM00000000Escherichia coli Spr2013_WWKa_OUT_5PRJNA380388SAMN06641839NBJN00000000Escherichia coli Spr2013_WWKa_OUT_55PRJNA380388SAMN06641838NBJO00000000Escherichia coli Spr2013_WWKa_OUT_32PRJNA380388SAMN06641837NBJP00000000Escherichia coli Spr2013_WWKa_OUT_45PRJNA380388SAMN06641822NBJQ00000000Escherichia coli Spr2013_WWKa_OUT_15PRJNA380388SAMN06641821NBJR00000000Escherichia coli Spr2013_WWKa_OUT_29PRJNA380388SAMN06641820NBJS00000000Escherichia coli Spr2013_WWKa_NEU_6PRJNA380388SAMN06641819NBJT00000000Escherichia coli Spr2013_WWKa_OUT_11PRJNA380388SAMN06641818NBJU00000000Escherichia coli Spr2013_WWKa_NEU_15PRJNA380388SAMN06641817NBJV00000000Escherichia coli Spr2013_WWKa_NEU_37PRJNA380388SAMN06641816NBJW00000000Escherichia coli Spr2013_WWKa_ALT_63PRJNA380388SAMN06641815NBJX00000000Escherichia coli Spr2013_WWKa_ALT_71PRJNA380388SAMN06641814NBJY00000000Escherichia coli Spr2013_WWKa_ALT_51PRJNA380388SAMN06641813NBJZ00000000Escherichia coli Spr2013_WWKa_ALT_55PRJNA380388SAMN06641812NBKA00000000Escherichia coli Spr2013_WWKa_ALT_43PRJNA380388SAMN06641811NBKB00000000Escherichia coli Spr2013_WWKa_ALT_27PRJNA380388SAMN06641810NBKC00000000Escherichia coli Spr2013_WWKa_ALT_41PRJNA380388SAMN06641809NBKD00000000Escherichia coli Spr2012_WWKa_OUT_37PRJNA380388SAMN06641808NBKE00000000Escherichia coli Spr2012_WWKa_OUT_54PRJNA380388SAMN06641807NBKF00000000Escherichia coli Spr2012_WWKa_OUT_25PRJNA380388SAMN06641806NBKG00000000Escherichia coli Spr2012_WWKa_OUT_3PRJNA380388SAMN06641805NBKH00000000Escherichia coli Spr2012_WWKa_OUT_16PRJNA380388SAMN06641804NBKI00000000Escherichia coli Spr2012_WWKa_OUT_13PRJNA380388SAMN06641803NBKJ00000000Escherichia coli Spr2012_WWKa_NEU_74PRJNA380388SAMN06641802NBKK00000000Escherichia coli Spr2012_WWKa_OUT_12PRJNA380388SAMN06641801NBKL00000000Escherichia coli Spr2012_WWKa_NEU_31PRJNA380388SAMN06641800NBKM00000000Escherichia coli Spr2012_WWKa_NEU_51PRJNA380388SAMN06641799NBKN00000000Escherichia coli Spr2012_WWKa_NEU_24PRJNA380388SAMN06641798NBKO00000000Escherichia coli Spr2012_WWKa_ALT_27PRJNA380388SAMN06641797NBKP00000000Escherichia coli Spr2012_WWKa_ALT_35PRJNA380388SAMN06641796NBKQ00000000Escherichia coli Aut2013_WWKa_OUT_3PRJNA380388SAMN06641793NBKR00000000Escherichia coli Aut2013_WWKa_OUT_10PRJNA380388SAMN06641792NBKS00000000Escherichia coli Aut2013_WWKa_OUT_20PRJNA380388SAMN06641791NBKT00000000Escherichia coli Aut2013_WWKa_NEU_51PRJNA380388SAMN06641789NBKU00000000Escherichia coli Aut2013_WWKa_NEU_53PRJNA380388SAMN06641788NBKV00000000Escherichia coli Aut2013_WWKa_NEU_44PRJNA380388SAMN06641786NBKW00000000Escherichia coli Aut2013_WWKa_ALT_65PRJNA380388SAMN06641785NBKX00000000Escherichia coli Aut2013_WWKa_NEU_28PRJNA380388SAMN06641784NBKY00000000Escherichia coli Aut2013_WWKa_ALT_59PRJNA380388SAMN06641782NBKZ00000000Escherichia coli Aut2013_WWKa_ALT_48PRJNA380388SAMN06641780NBLA00000000Escherichia coli Aut2013_WWKa_ALT_45PRJNA380388SAMN06641779NBLB00000000Escherichia coli Aut2013_WWKa_ALT_30PRJNA380388SAMN06641778NBLC00000000Escherichia coli Aut2013_WWKa_ALT_17PRJNA380388SAMN06641777NBLD00000000Escherichia coli Aut2013_WWKa_ALT_13PRJNA380388SAMN06670745NBNO00000000Escherichia coli Win2012_WWKa_OUT_19

Pan- and core-genome {#Sec20}
--------------------

To generate the pan- and core-genome size graph we followed the procedure in^[@CR3],[@CR28]^. We had 92 genomes available. We varied *i* from one to 92. At each subset size *i*, we randomly selected *i* genomes and computed the sizes of the union (pan) and intersection (core) of gene clusters. This random selection was carried out 2000 times in each step.

Gene clusters to rank genes by correlation to phenotype {#Sec21}
-------------------------------------------------------

Prokka genes were identified in all isolate genomes and then clustered with CD-HIT at 60% sequence identity and 50% coverage (arguments -n 4 -c 0.6 -G 1 -aL 0.8 -aS 0.5 -B 1). A 80% identity cutoff was also tried but dismissed, because the 60% threshold yielded 25% less clusters while adequately clustering homologous gene sequences with lower sequence similarity. This threshold value is also supported by the widespread default use of the BLOSUM62 matrix, the basis of which is sequences clustered by 62% sequence identity.

Tree {#Sec22}
----

The phylogenetic tree of 92 isolates was built following the procedure of^[@CR43],[@CR44]^ using FastTree version 2.1^[@CR45]^. Sequence reads were aligned to *E*. *coli* K12 MG 1665 and single nucleotide variant calling was carried out using GATK^[@CR46]^. Quality control for variant calling was performed; variants supported by more than ten reads or likelihood score greater than 200 were always in the range of 84--99% of variants called per isolate with the exception of 2 isolates where only 59% and 60% of the variants were above the threshold for quality and supporting reads. FastTree 2.1^[@CR45]^ was then used to build the maximum likelihood tree based on core single nucleotide polymorphisms derived from variant calling. **Phylogrouping**. For phylogrouping, the in-silico classification method established by Salipante *et al*.^[@CR3]^ based on the classical classification by Clermont *et al*.^[@CR23]^ was employed. BLAST was performed to check each genome assembly for presence or absence of the genetic elements *chuA* and *yjaA* and the DNA fragment TspE4.C2 with an identity cutoff ≥90%.

MLST {#Sec23}
----

Concerning epidemiology and Multi-Locus Sequence Typing, we used the webserver at <https://cge.cbs.dtu.dk/services/MLST/> that follows the MLST scheme in^[@CR47]^ for predicting MLSTs from whole genome sequence data^[@CR48]^. 92 Draft genome assemblies were submitted and results were obtained; 2 isolates were unidentified demonstrating novel sequence types and have been assigned sequence types ST-8059 and ST-8060 by EnteroBase (<https://enterobase.warwick.ac.uk/>).

Virulence factors {#Sec24}
-----------------

Virulence factors protein sequences were downloaded from VFDB: Virulence Factors database^[@CR21],[@CR49]^. 2180 sequences, which are *E*. *coli* related, were chosen. Sequences were then clustered at 80% sequence identity using CD-HIT (version 4.6.3, arguments -n 4 -c 0.8 -G 1 -aL 0.8 -aS 0.8 --B 1) to 844 clusters. A virulence factor was considered present in an isolate's genome if there is a Prokka gene in the genome that has over 80% sequence identity and coverage against the virulence factor cluster representative.

ExPEC classification {#Sec25}
--------------------

There are intra- and extra-intestinal pathogenic *Escherichia coli*, which can be classified from the presence of virulence factors^[@CR50]--[@CR53]^. InPEC are characterised by the virulence factors stx1, stx2, escV, and bfpB. They are ExPEC if they contain over 20 of 58 virulence factors afa/draBC, bmaE, gafD, iha cds, mat, papEF, papGII, III, sfa/foc, etsB, etsC, sitD ep, sitD ch, cvaC MPIII, colV MPIX, eitA, eitC, iss, neuC, kpsMTII, ompA, ompT, traT, hlyF, GimB, malX, puvA, yqi, stx1, stx2, escV, bfp, feob, aatA, csgA, fimC, focG, nfaE, papAH, papC, sfaS, tsh, chuA, fyuA, ireA, iroN, irp2, iucD, iutA, sitA, astA, cnf1, sat, vat, hlyA, hlyC, ibeA, tia, and pic.

Data availability {#Sec26}
-----------------

Genome assemblies of the analyzed isolates that support the findings of the study will be made available on the NCBI upon paper publication (see Table [2](#Tab2){ref-type="table"}).
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